Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Back to staff profile
Prize And Awards
- External Examiner
- Recipient
- 24/2/2025
- Top-ranked research paper in the Seventh Excellent Paper Symposium (1st Position)
- Recipient
- 16/11/2024
- Honorary Reader in Pharmacoepidemiology and Pharmacy Practice, NHS Lanarkshire, Scotland.
- Recipient
- 1/3/2024
- Best Researcher (Poster winner)
- Recipient
- 11/2/2024
- Reproducibility Recognition by HDR UK as a member of EAVE II – Early Pandemic Evaluation and Enhanced Surveillance of COVID-19
- Recipient
- 31/1/2024
- Honorary Appointment at Public Health Scotland
- Recipient
- 1/10/2023
Back to staff profile
Publications
- Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a multi-stakeholders Nominal Group Technique (NGT) consensus method
- Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj
- 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences (2025)
- Trigger a surge in hypertension and high cholesterol? A nationwide study on Scotland's post-pandemic prescribing trends and healthcare system recovery
- Kurdi Amanj, Millar Morven, Nnabuko Uchenna, McTaggart Stuart, Mueller Tanja, Proud Euan, Melia Barry, Bennie Marion
- The 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences 2025 (2025)
- Trends and changes in polypharmacy prevalence in the UK between 2010 to 2016 : retrospective cohort study using the UK Biobank data
- Madanat Faisal, Mueller Tanja, Kurdi Amanj
- European Drug Utilization Research Group conference 2025 (EuroDURG) (2025)
- Exploration of the regional variation of the impact of COVID-19 on antidiabetic prescribing
- Kurdi Amanj, Cunningham Eoin
- European Drug Utilization Research Group conference 2025 (EuroDURG) (2025)
- The impact of COVID-19 on primary care antidiabetic prescription utilisation in England : an interrupted segmented regression analysis
- Lazrek Sara, Kurdi Amanj
- European Drug Utilization Research Group conference 2025 (EuroDURG) (2025)
- Profiling the pattern of medication use during pregnancy : a scoping review of population-based studies
- Parvin Mst Irin, Abunimeh Hanan Nabeel, Alshammari Hisham Abdulaziz M, Kurdi Amanj, Bennie Marion, Mueller Tanja
- European Drug Utilization Research Group conference 2025 (EuroDURG) (2025)
Back to staff profile
Professional Activities
- Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
- Speaker
- 29/10/2025
- NORDIC Social Pharmacy Conference 2025
- Organiser
- 4/6/2025
- External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
- Examiner
- 24/2/2025
- Iraqi Journal of Pharmacy (Journal)
- Peer reviewer
- 13/8/2024
- Positioning Pharmacists in advancing Primary Health Care
- Speaker
- 13/6/2024
- Advances in Pharmacy and Pharmacoepidemiology Education in Kenya and Globally
- Speaker
- 13/6/2024
Projects
- Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Cancer Medicines Outcomes Programme - Public Health Scotland
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Prescribing medicines use in pregnancy: A scoping review protocol
- Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
- Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
- 10-Jan-2024 - 14-Jan-2024
- PHS Medicines Programme
- Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
- 01-Jan-2023 - 30-Jan-2028
- Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
- Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
- 01-Jan-2023 - 30-Jan-2027
- 22/145 Systems Engineering Innovation hubs for Multiple longterm Conditions - Development phase
- Maier, Anja (Principal Investigator) Connolly, Patricia (Co-investigator) Gray, Louise (Co-investigator) Inns, Tom (Co-investigator) Kurdi, Amanj (Co-investigator) Maguire, Roma (Co-investigator) Mehnen, Jorn (Co-investigator) Michie, Craig (Co-investigator) Mueller, Tanja (Co-investigator) Picanco Rodrigues, Vinicius (Co-investigator) Tachtatzis, Christos (Co-investigator) Whitfield, Ian (Co-investigator)
- 01-Jan-2023 - 31-Jan-2025
Back to staff profile
Contact
Professor
Amanj
Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181